alanylglutamine has been researched along with Injury, Myocardial Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, QL; Geng, J; Liu, S; Song, YQ; Yang, Y | 1 |
| Dauber, I; Hamiel, C; Queensland, K; Rooyackers, O; Sufit, A; Weitzel, LB; Wischmeyer, PE | 1 |
1 trial(s) available for alanylglutamine and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Pharmacologically dosed oral glutamine reduces myocardial injury in patients undergoing cardiac surgery: a randomized pilot feasibility trial.
Topics: Administration, Oral; Aged; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Creatine Kinase; Dipeptides; Dose-Response Relationship, Drug; Double-Blind Method; Feasibility Studies; Female; Glutamine; HSP70 Heat-Shock Proteins; Humans; Male; Middle Aged; Myocardial Reperfusion Injury; Myoglobin; Pilot Projects; Polysaccharides; Treatment Outcome; Troponin | 2012 |
1 other study(ies) available for alanylglutamine and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Protective effects of N(2)‑L‑alanyl‑L‑glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion.
Topics: Animals; Biomarkers; Cardiotonic Agents; Collagen; Cytokines; Dipeptides; Hemodynamics; Inflammation Mediators; Janus Kinase 2; Male; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Rats; Signal Transduction; STAT3 Transcription Factor | 2018 |